|
RAB33B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99960056793225E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44170017538181E-10 |
| Normal-vs-Stage2 |
2.73260000183129E-08 |
| Normal-vs-Stage3 |
4.94170004916583E-09 |
| Normal-vs-Stage4 |
1.11140000536025E-08 |
| Stage1-vs-Stage2 |
5.762400E-02 |
| Stage1-vs-Stage3 |
4.592400E-01 |
| Stage1-vs-Stage4 |
1.251370E-01 |
| Stage2-vs-Stage3 |
2.247600E-01 |
| Stage2-vs-Stage4 |
7.178000E-01 |
| Stage3-vs-Stage4 |
3.774000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.83070250467676E-11 |
| Normal-vs-AfricanAmerican |
2.660900E-03 |
| Normal-vs-Asian |
1.78396999999109E-05 |
| Caucasian-vs-AfricanAmerican |
4.263400E-01 |
| Caucasian-vs-Asian |
6.687400E-01 |
| AfricanAmerican-vs-Asian |
6.733200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82709958274074E-10 |
| Normal-vs-Female |
2.52670107059316E-11 |
| Male-vs-Female |
4.280000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.76530000406805E-08 |
| Normal-vs-Age(41-60Yrs) |
2.63840005398919E-09 |
| Normal-vs-Age(61-80Yrs) |
4.46319980973442E-10 |
| Normal-vs-Age(81-100Yrs) |
1.022190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.638300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.034000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.951000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.819400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.503030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.420430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.240200E-01 |
| Classical-VS-Follicular |
2.79650000001297E-06 |
| Classical-VS-Other |
4.934200E-01 |
| Classical-VS-Normal |
2.44100000001968E-06 |
| Tall-VS-Follicular |
1.437890E-02 |
| Tall-VS-Other |
6.553200E-01 |
| Tall-VS-Normal |
5.54560000000093E-05 |
| Follicular-VS-Other |
3.742000E-01 |
| Follicular-VS-Normal |
3.6198044561786E-11 |
| Other-VS-Normal |
1.509750E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.26751991919627E-13 |
| Normal-vs-N1 |
1.25620000002158E-06 |
| N0-vs-N1 |
2.973200E-01 |
|
|
